|
07 Mar 2008 |
Alkermes Provides Update on Inhaled Insulin Program
|
|
07 Mar 2008 |
AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
|
|
07 Mar 2008 |
Lilly Announces Termination of AIR Insulin Program
|
|
06 Mar 2008 |
PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
|
|
06 Mar 2008 |
CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
|
|
05 Mar 2008 |
Biovitrum and Syntonix set to begin phase I/IIa clinical trial of long-acting recombinant Factor IXFc for the treatment of Hemophilia B
|
|
05 Mar 2008 |
Chemokine Therapeutics Receives Approval From Health Canada to Commence Phase II Study in Liver Cancer
|
|
05 Mar 2008 |
EU Commission Approves Updated Prescribing Information for Aranesp(R)
|
|
03 Mar 2008 |
Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery
|
|
03 Mar 2008 |
Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimer's Disease
|
|
29 Feb 2008 |
OrthoLogic Announces Initiation of Dosing for AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
|
|
28 Feb 2008 |
PAION's anticoagulant Solulin successfully tested in first-in-man study
|
|
28 Feb 2008 |
Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
|
|
28 Feb 2008 |
Savient Provides Further Information on Top Line Phase 3 Trials Results for Puricase(R) (pegloticase)
|
|
26 Feb 2008 |
Agennix's Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer
|
|
26 Feb 2008 |
Allon's Phase II clinical trial shows statistically significant efficacy on human cognition and memory
|
|
22 Feb 2008 |
FORSTEO(R) Receives Positive Opinion from the European Committee for Medicinal Products for Human Use for the Treatment of Glucocorticoid-Induced Osteoporosis
|
|
22 Feb 2008 |
Artisan Pharma's Lead Product, ART-123, Approved in Japan
|
|
21 Feb 2008 |
Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A
|
|
20 Feb 2008 |
Antisense Therapeutics Ltd Licenses ATL1102 to Teva Pharmaceutical Industries Ltd.
|
|
20 Feb 2008 |
ConjuChem Initiates Phase II Study of PC-DAC(TM):Exendin-4
|
|
20 Feb 2008 |
Stem Cell Therapeutics Announces Favorable Results From the Phase IIa BETAS Stroke Trial
|
|
14 Feb 2008 |
Cytheris Announces 48-Week Results of Phase I/II Study Showing Administration of Interleukin-7 (IL-7) Significantly Improves CD4 T-Cell Counts in Chronically Infected HIV-1 Patients
|
|
13 Feb 2008 |
Unigene Announces Publication of Initial Results of Site-Directed Bone Growth Studies
|
|
12 Feb 2008 |
Æterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
|
